Clinical Trial

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

Name: Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo — clinical trial record (NCT07524946)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.

Protocol Amendment History 2 changes

critical Recruitment opened 2026-07-30

notable Trial sites expanded: 0 -> 15 locations 2026-07-30

Trial Details

NCT Number	NCT07524946
Lead Sponsor	Bausch Health Americas, Inc. Collaborators: MedTrials Incorporated
Conditions	Acne Vulgaris
Enrollment	100 participants
Start Date	2026-04-01
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-29